Ikarian Capital, LLC Horizon Therapeutics Public LTD CO Transaction History

Ikarian Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $935,850 - $1.71 Million	15,000 Added 20.21%	89,219 $10.2 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $5.06 Million - $7.27 Million	-85,897 Reduced 53.65%	74,219 $4.59 Million
Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $3.97 Million - $5.82 Million	50,000 Added 45.41%	160,116 $12.8 Million
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $2.98 Million - $3.78 Million	34,455 Added 45.54%	110,116 $11.6 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $4.93 Million - $6 Million	50,000 Added 194.85%	75,661 $8.15 Million

Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $2.68 Million - $3.22 Million	-29,154 Reduced 53.19%	25,661 $2.81 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $4.68 Million - $5.2 Million	54,212 Added 8990.38%	54,815 $5.13 Million
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $146,389 - $194,588	-2,038 Reduced 77.17%	603 $56,000
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $145,862 - $211,095	2,641 New	2,641 $205,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.